共 128 条
- [1] Sirois C(2019)Mixed bag “polypharmacy”: methodological pitfalls and challenges of this exposure definition Curr Epidemiol Rep 6 390-401
- [2] Simard M(2020)Adverse outcomes of polypharmacy in older people: systematic review of reviews J Am Med Dir Assoc 21 181-187
- [3] Gosselin E(2013)Polypharmacy: a necessary evil BMJ 347 f7033-184
- [4] Gagnon M-E(2004)Aging biology and geriatric clinical pharmacology Pharmacol Rev 56 163-2246
- [5] Roux B(2015)American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults J Am Geriatr Soc 63 2227-218
- [6] Laroche M-L(2015)STOPP/START criteria for potentially inappropriate prescribing in older people: version 2 Age Ageing 44 213-1196
- [7] Davies LE(2018)An update on the clinical consequences of polypharmacy in older adults: a narrative review Expert Opin Drug Saf 17 1185-1644
- [8] Spiers G(2015)Any versus long-term prescribing of high risk medications in older people using 2012 Beers criteria: results from three cross-sectional samples of primary care records for 2003/4, 2007/8 and 2011/12 BMC Geriatr 15 146-619
- [9] Kingston A(2015)Trends and interaction of polypharmacy and potentially inappropriate prescribing in primary care over 15 years in Ireland: a repeated cross-sectional study BMJ Open 5 1633-386
- [10] Todd A(2018)The associations of geriatric syndromes and other patient characteristics with the current and future use of potentially inappropriate medications in a large cohort study Eur J Clin Pharmacol 74 614-500